Metastatic Renal Cell Carcinoma in the Thyroid Gland and Pancreas Showing Uptake on 68Ga DOTATATE PET/CT Scan

被引：18
|
作者：
Kanthan, Gowri L. [1 ,2 ]
Schembri, Geoffrey Paul [1 ]
Samra, Jaswinder [3 ]
Roach, Paul [1 ]
Hsiao, Edward [1 ]
机构：
[1] Royal N Shore Hosp, Dept Nucl Med, Reserve Rd, St Leonards, NSW 2065, Australia
[2] Prince Wales Hosp, Dept Radiol, Randwick, NSW 2031, Australia
[3] Royal N Shore Hosp, Dept Surg, Sydney, NSW, Australia
来源：
CLINICAL NUCLEAR MEDICINE | 2016年 / 41卷 / 07期
关键词：
Ga-68 DOTATATE PET/CT; renal cell carcinoma; neuroendocrine tumors; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; GA-68-DOTATATE PET/CT; CANCER;
D O I：
10.1097/RLU.0000000000001227
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Ga-68 DOTATATE PET/CT is an imaging technique used in the diagnosis of neuroendocrine tumors. We report a case of 66-year-old woman with a history of surgically removed renal cell carcinoma who presented for a DOTATATE PET/CT scan to characterize a newly diagnosed pancreatic lesion. DOTATATE-avid lesions were identified in the thyroid gland and pancreas. Subsequent biopsy confirmed the diagnosis of metastatic renal cell carcinoma at both sites. It is important to be aware that tumors other than neuroendocrine tumors may also show uptake on DOTATATE PET/CT scan. A biopsy may be required if lesions are identified at atypical sites.
引用
收藏
页码：583 / 584
页数：2
相关论文
共 50 条
  • [1] Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT
    Chan, Mico
    Schembri, Geoffrey Paul
    Hsiao, Edward
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) : 56 - 57
  • [2] Improvement in Diagnosis of Metastatic Pituitary Carcinoma by 68Ga DOTATATE PET/CT
    Xiao, Jianqi
    Zhu, Zhaohui
    Zhong, Dingrong
    Ma, Wenbin
    Wang, Renzhi
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (02) : E129 - E131
  • [3] 68Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland
    Low, Han Chung
    Loke, Kelvin Siu Hoong
    Wang, Fu Qiang
    Han, Shuting
    Nei, Wen Long
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1056 - 1058
  • [4] METASTATIC CLEAR CELL RENAL CELL CARCINOMA DEMONSTRATING FOCAL UPTAKE ON 68GA-DOTATATE PET
    Nadebaum, D.
    Lee, S.
    Nikfarjam, M.
    Scott, A.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 37 - 37
  • [5] Interim Results on the Influence of Lanreotide on Uptake of [68Ga]-DOTATATE in Patients with Metastatic or Unresectable NET: No Evidence for Discontinuation of Lanreotide before [68Ga]-DOTATATE PET/CT
    Aalbersberg, E.
    Saveur, L.
    Tesselaar, M.
    Stokkel, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 54 - 54
  • [6] Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT
    Papadakis, Georgios Z.
    Millo, Corina
    Sadowski, Samira M.
    Bagci, Ulas
    Patronas, Nicholas J.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (10) : 783 - 784
  • [7] 68Ga DOTATATE PET/CT in Differentiated Thyroid Carcinoma With Fibular Metastasis and Mixed Response to Sorafenib
    Basu, Sandip
    Joshi, Amit
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (10) : 772 - 773
  • [8] Head to Head Comparison of [68Ga]Ga-FAPI-04 and [68Ga]Ga-DOTATATE PET/CT in Patients With Recurrence Medullary Thyroid Carcinoma
    Isik, E.
    Civan, C.
    Simsek, D. Has
    Ozkan, Z. G.
    Gul, N.
    Erturk, S. M.
    Sanli, Y.
    Kuyumcu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S508 - S508
  • [9] Interim Results in 19 Patients on the Influence of Lanreotide on Uptake of [68Ga]-DOTATATE in Patients with Metastatic or Unresectable NET: No Evidence for Discontinuation of Lanreotide before [68Ga]-DOTATATE PET/CT
    Aalbersberg, E. A.
    Saveur, L. J.
    Tesselaar, M. E. T.
    Stokkel, M. P. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S91 - S91
  • [10] 68Ga DOTATATE PET/CT Imaging of Elastofibroma Dorsi
    Ishiyama, Mitsutomi
    Vesselle, Hubert
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (05) : E154 - E155
12345